7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride and Alloxan Diabetes

7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, YJ; Kim, WB; Kwon, JW; Lee, HJ; Lee, MG; Yang, J	1

Other Studies

1 other study(ies) available for 7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride and Alloxan Diabetes

Article	Year
Pharmacokinetic changes of M1, M2, M3, and M4 after intravenous administration of a new anthracycline, DA-125, to alloxan-induced diabetes mellitus rats. Research communications in molecular pathology and pharmacology, 1996, Volume: 94, Issue:2 Topics: Alloxan; Animals; Antibiotics, Antineoplastic; Area Under Curve; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Doxorubicin; Half-Life; Kidney; Liver; Organ Size; Rats; Rats, Sprague-Dawley; Tissue Distribution	1996

Article

Year

Pharmacokinetic changes of M1, M2, M3, and M4 after intravenous administration of a new anthracycline, DA-125, to alloxan-induced diabetes mellitus rats.

Research communications in molecular pathology and pharmacology, 1996, Volume: 94, Issue:2

Topics: Alloxan; Animals; Antibiotics, Antineoplastic; Area Under Curve; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Doxorubicin; Half-Life; Kidney; Liver; Organ Size; Rats; Rats, Sprague-Dawley; Tissue Distribution

1996